Epidemiology of community-associated methicillin-resistant Staphylococcus aureus in San Francisco children

Journal of Pediatric Infectious Diseases

Volumn 4, Issue 3, 2009, Pages 247-259

  Hermos, Christina R ^a   Shiau, Rita ^a   Hsiang, Michelle ^a   Chambers, Henry F ^b   Pan, Erica ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Community associated infections; Methicillin resistance; Risk factors; Soft tissue infections; Staphylococcus aureus

Indexed keywords

ANTIBIOTIC AGENT; CEPHALOSPORIN; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; GENTAMICIN; PENICILLIN G; TETRACYCLINE;

AFRICAN AMERICAN; AGE DISTRIBUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATION; CAUCASIAN; CHILD; CHILD HEALTH CARE; COMMUNICABLE DISEASE; COMMUNITY EXPOSURE; ETHNIC DIFFERENCE; EXPOSURE; FEMALE; HISPANIC; HUMAN; INFANT; INTERVIEW; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; PACIFIC ISLANDER; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; SOFT TISSUE INFECTION; STAPHYLOCOCCUS AUREUS; UNITED STATES;

EID: 68349133376     PISSN: 13057707     EISSN: None     Source Type: Journal    
DOI: 10.3233/JPI-2009-0169     Document Type: Article

References (44)

1. T.S. Naimi, K.H. LeDell, K. Como-Sabetti et al., Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection, JAMA 290 (2003), 2976-2984.
2. B.C. Herold, L.C. Immergluck, M.C. Maranan et al., Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk, JAMA 279 (1998), 593-598.
3. S.C. Buckingham, L.K. McDougal, L.D. Cathey et al., Emergence of community-associated methicillin-resistant Staphylococcus aureus at a Memphis, Tennessee Children's Hospital, Pediatr Infect Dis J 23 (2004), 619-624.
4. D.W. Dietrich, D.B. Auld and L.A. Mermel, Community-acquired methicillin-resistant Staphylococcus aureus in southern New England children, Pediatrics 113 (2004), 347-352.
5. J.E. Fergie and K. Purcell, Community-acquired methicillin-resistant Staphylococcus aureus infections in south Texas children, Pediatr Infect Dis J 20 (2001), 860-863.
6. C.D. Salgado, B.M. Farr and D.P. Calfee, Community-acquired methicillin-resistant Staphylococcus aureus: A metaanalysis of prevalence and risk factors, Clin Infect Dis 36 (2003), 131-139.
7. C.A. Sattler, E.O. Mason, Jr. and S.L. Kaplan, Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children, Pediatr Infect Dis J 21 (2002), 910-917.
8. Centers for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus: Minnesota and North Dakota, 1997-1999, MMWR 48 (1999), 707-710.
9. H.F. Chambers, The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis 7 (2001), 178-182.
10. R. Shahin, I.L. Johnson, F. Jamieson, A. McGeer, J. Tolkin and E.L. Ford-Jones, Methicillin-resistant Staphylococcus aureus carriage in a child care center following a case of disease. Toronto Child Care Center Study Group, Arch Pediatr Adolesc Med 153 (1999), 864-868.
11. P.M. Adcock, P. Pastor, F. Medley, J.E. Patterson and T.V. Murphy, Methicillin-resistant Staphylococcus aureus in two child care centers, J Infect Dis 178 (1998), 577-580.
12. R.J. Hollis, J.L. Barr, B.N. Doebbeling, M.A. Pfaller and R.P. Wenzel, Familial carriage of methicillin-resistant Staphylococcus aureus and subsequent infection in a premature neonate, Clin Infect Dis 21 (1995), 328-332.
13. Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus infections among competitive sports participants - Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000-2003, MMWR 52 (2003), 793-795.
14. J.M. Lindenmayer, S. Schoenfeld, R. O'Grady and J.K. Carney, Methicillin-resistant Staphylococcus aureus in a high school wrestling team and the surrounding community, Arch Intern Med 158 (1998), 895-899.
15. L.D. Saravolatz, N. Markowitz, L. Arking, D. Pohlod and E. Fisher, Methicillin-resistant Staphylococcus aureus. Epidemiologic observations during a community-acquired outbreak, Ann Intern Med 96 (1982), 11-16.
16. F. Fleisch, R. Zbinden, C.Vanoli and C. Ruef, Epidemic spread of a single clone of methicillin-resistant Staphylococcus aureus among injection drug users in Zurich, Switzerland, Clin Infect Dis 32 (2001), 581-586.
17. E.D. Charlebois, D.R. Bangsberg, N.J. Moss et al., Population-based community prevalence of methicillin-resistant Staphylococcus aureus in the urban poor of San Francisco, Clin Infect Dis 34 (2002), 425-433.
18. S. Bassetti and M. Battegay, Staphylococcus aureus infections in injection drug users: Risk factors and prevention strategies, Infection 32 (2004), 163-169.
19. Centers for Disease Control and Prevention. Methicillin-Resistant Staphylococcus aureus infections in correctional facilities - georgia, California, and Texas, 2001-2003, MMWR 52 (2003), 992-996.
20. Centers for Disease Control and Prevention. Methicillin-Resistant Staphylococcus aureus skin or soft tissue infections in a state prison - Mississippi, 2000, MMWR 50 (2001), 919-922.
21. Centers for Disease Control and Prevention. Public health dispatch: outbreaks of community-associated methicillin-resistant Staphylococcus aureus Skin Infections - Los Angeles County, California, 2002-2003, MMWR 52 (2003), 88.
22. D.M. Young, H.W. Harris, E.D. Charlebois et al., An epidemic of methicillin-resistant Staphylococcus aureus soft tissue infections among medically underserved patients, Arch Surg 139 (2004), 947-951.
23. E.S. Pan, B.A. Diep, H.A. Carleton et al., Increasing prevalence of methicillin-resistant Staphylococcus aureus infection in California jails, Clin Infect Dis 37 (2003), 1384-1388.
24. S.K. Fridkin, J.C. Hageman, M. Morrison et al., Methicillin-resistant Staphylococcus aureus disease in three communities, N Engl J Med 352 (2005), 1436-1444.
25. L.G. Miller, F. Perdreau-Remington, A.S. Bayer et al., Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin-susceptible S. aureus infection: A prospective investigation, Clin Infect Dis 44 (2007), 471-482.
26. G.J. Moran, A. Krishnadasan, R.J. Gorwitz et al., Methicillin-resistant S. aureus infections among patients in the emergency department, N Engl J Med 355 (2006), 666-674.
27. J.M. Buck, K. Como-Sabetti, K.H. Harriman et al., Community-associated methicillin-resistant Staphylococcus aureus, Minnesota, 2000-2003, Emerg Infect Dis 11 (2005), 1532-1538.
28. Performance Standards for Antimicrobials Susceptibility Testing; Seventeenth Informational Supplement M100-S17 Vol. 27 No. 1.
29. H.A. Carleton, B.A. Diep, E.D. Charlebois, G.F. Sensabaugh and F. Perdreau-Remington, Community-adapted methicillin-resistant Staphylococcus aureus (MRSA): Population dynamics of an expanding community reservoir of MRSA, J Infect Dis 190 (2004), 1730-1738.
30. C. Liu, C.J. Graber, M. Karr et al., A population-based study of the incidence and molecular epidemiology of methicillin-resistant Staphylococcus aureus disease in San Francisco, 2004-2005, Clin Infect Dis 46 (2008), 1637-1646.
31. M.Z. David, S.E. Crawford, S. Boyle-Vavra, M.A. Hostetler, D.C. Kim and R.S. Daum, Contrasting pediatric and adult methicillin-resistant Staphylococcus aureus isolates, Emerg Infect Dis 12 (2006), 631-637.
32. R. Aly, H.I. Maibach and H.R. Shinefield, Microbial flora of atopic dermatitis, Arch Dermatol 113 (1977), 780-782.
33. T.J. David and G.C. Cambridge, Bacterial infection and atopic eczema, Arch Dis Child 61 (1986), 20-23.
34. H.M. Goodyear, P.J.Watson, S.A. Egan, E.H. Price, P.A. Kenny and J.I. Harper, Skin microflora of atopic eczema in first time hospital attenders, Clin Exp Dermatol 18 (1993), 300-304.
35. I. Brook, E.H. Frazier and J.K. Yeager, Microbiology of infected atopic dermatitis, Int J Dermato 35 (1996), 791-793.
36. R. Bunikowski, M.E. Mielke, H. Skarabis et al., Evidence for a disease-promoting effect of Staphylococcus aureus-derived exotoxins in atopic dermatitis, J Allergy Clin Immunol 105 (2000), 814-819.
37. G. Ricci, A. Dondi and A. Patrizi, Staphylococcus aureus over-infection in atopic dermatitis, J Pediatr Infect Dis 3 (2008), 83-90.
38. P.D. Arkwright, T.O. Daniel, D. Sanyal, T.J. David and L. Patel, Age-related prevalence and antibiotic resistance of pathogenic staphylococci and streptococci in children with infected atopic dermatitis at a single-specialty center, Arch Dermatol 138 (2002), 939-941.
39. C.A. Morin and J.L. Hadler, Population-based incidence and characteristics of community-onset Staphylococcus aureus infections with bacteremia in 4 metropolitan Connecticut areas, 1998, J Infect Dis 184 (2001), 1029-1034.
40. M.D. King, B.J. Humphrey, Y.F. Wang, E.V. Kourbatova, S.M. Ray and H.M. Blumberg, Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections, Ann Intern Med 144 (2006), 309-317.
41. K.G. Hultén, S.L. Kaplan, B.E. Gonzalez et al., Three-year surveillance of community onset health care-associated Staphylococcus aureus infections in children, Pediatr Infec Dis J 25 (2006), 349-353.
42. C.L. Maree, R.S. Daum, S. Boyle-Vavra, K. Matayoshi and L.G. Miller, Community-associated methicillin-resistant Staphylococcus aureus isolates causing healthcare-associated infections, Emerg Infect Dis 13 (2007), 236-242.
43. R.M. Klevens, M.A. Morrison, J. Nadle et al., Invasive methicillin-resistant Staphylococcus aureus infections in the United States, JAMA 298 (2007), 1763-1771.
44. M.Z. David, D. Glikman, S.E. Crawford et al., What is community-associated methicillin-resistant Staphylococcus aureus? J Infect Dis 197 (2008), 1235-1243.